Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 135

Similar articles for PubMed (Select 2106384)

1.

The effects of different cumulative doses of chemotherapy on testicular function. Results in 75 patients treated for Hodgkin's disease during childhood or adolescence.

Brämswig JH, Heimes U, Heiermann E, Schlegel W, Nieschlag E, Schellong G.

Cancer. 1990 Mar 15;65(6):1298-302.

PMID:
2106384
2.

The effects of etoposide on testicular function in boys treated for Hodgkin's disease.

Gerres L, Brämswig JH, Schlegel W, Jürgens H, Schellong G.

Cancer. 1998 Nov 15;83(10):2217-22.

PMID:
9827728
3.

[Testicular function after OPA/COMP chemotherapy without procarbazine in boys with Hodgkin's disease. Results in 25 patients of the DAL-HD-85 study].

Hassel JU, Brämswig JH, Schlegel W, Schellong G.

Klin Padiatr. 1991 Jul-Aug;203(4):268-72. German.

PMID:
1942933
4.

Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma.

Bokemeyer C, Schmoll HJ, van Rhee J, Kuczyk M, Schuppert F, Poliwoda H.

Ann Hematol. 1994 Mar;68(3):105-10.

PMID:
8167175
5.

Decreased serum inhibin B/FSH ratio as a marker of Sertoli cell function in male survivors after chemotherapy in childhood and adolescence.

Bordallo MA, Guimarães MM, Pessoa CH, Carriço MK, Dimetz T, Gazolla HM, Dobbin J, Castilho IA.

J Pediatr Endocrinol Metab. 2004 Jun;17(6):879-87.

PMID:
15270406
6.

[Changes in gonadal function in post-pubertal male survivors of acute lymphoblastic leukemia and Hodgkin's disease].

Soriano Guillén L, Muñoz Calvo MT, Pozo Román J, Contra Gómez T, Buño Soto M, Argente Oliver J.

An Esp Pediatr. 2000 Oct;53(4):318-23. Spanish.

PMID:
11083980
7.
9.

Irreversible gonadal damage in male survivors of pediatric Hodgkin's disease.

Heikens J, Behrendt H, Adriaanse R, Berghout A.

Cancer. 1996 Nov 1;78(9):2020-4.

PMID:
8909325
10.

Assessment of male fertility in patients with Hodgkin's lymphoma treated in the German Hodgkin Study Group (GHSG) clinical trials.

Sieniawski M, Reineke T, Josting A, Nogova L, Behringer K, Halbsguth T, Fuchs M, Diehl V, Engert A.

Ann Oncol. 2008 Oct;19(10):1795-801. doi: 10.1093/annonc/mdn376. Epub 2008 Jun 9.

11.

Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study.

Mauz-Körholz C, Hasenclever D, Dörffel W, Ruschke K, Pelz T, Voigt A, Stiefel M, Winkler M, Vilser C, Dieckmann K, Karlén J, Bergsträsser E, Fosså A, Mann G, Hummel M, Klapper W, Stein H, Vordermark D, Kluge R, Körholz D.

J Clin Oncol. 2010 Aug 10;28(23):3680-6. doi: 10.1200/JCO.2009.26.9381. Epub 2010 Jul 12.

12.

Reproductive and endocrine gonadal capacity in patients treated with COPP chemotherapy for Hodgkin's disease.

Kreuser ED, Xiros N, Hetzel WD, Heimpel H.

J Cancer Res Clin Oncol. 1987;113(3):260-6.

PMID:
3108263
13.

Gonadal function in prepubertal boys following treatment for Hodgkin's disease.

Dhabhar BN, Malhotra H, Joseph R, Garde S, Bhasin S, Sheth A, Advani SH.

Am J Pediatr Hematol Oncol. 1993 Aug;15(3):306-10.

PMID:
8328644
14.

Gonadal function in young patients successfully treated for Hodgkin disease.

Papadakis V, Vlachopapadopoulou E, Van Syckle K, Ganshaw L, Kalmanti M, Tan C, Sklar C.

Med Pediatr Oncol. 1999 May;32(5):366-72.

PMID:
10219339
15.

Gonadal function following ABVD therapy for Hodgkin's disease.

Kulkarni SS, Sastry PS, Saikia TK, Parikh PM, Gopal R, Advani SH.

Am J Clin Oncol. 1997 Aug;20(4):354-7.

PMID:
9256888
16.

Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood.

van Beek RD, Smit M, van den Heuvel-Eibrink MM, de Jong FH, Hakvoort-Cammel FG, van den Bos C, van den Berg H, Weber RF, Pieters R, de Muinck Keizer-Schrama SM.

Hum Reprod. 2007 Dec;22(12):3215-22. Epub 2007 Nov 2.

17.

High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group.

Schellong G, Pötter R, Brämswig J, Wagner W, Prott FJ, Dörffel W, Körholz D, Mann G, Rath B, Reiter A, Weissbach G, Riepenhausen M, Thiemann M, Schwarze EW.

J Clin Oncol. 1999 Dec;17(12):3736-44.

PMID:
10577845
18.

Testicular function following the treatment of Hodgkin's disease in childhood.

Shafford EA, Kingston JE, Malpas JS, Plowman PN, Pritchard J, Savage MO, Eden OB.

Br J Cancer. 1993 Dec;68(6):1199-204.

19.

Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group.

Schellong G, Riepenhausen M, Creutzig U, Ritter J, Harbott J, Mann G, Gadner H.

J Clin Oncol. 1997 Jun;15(6):2247-53.

PMID:
9196137
20.

Does bulky disease at diagnosis influence outcome in childhood Hodgkin's disease and require higher radiation doses? Results from the German-Austrian Pediatric Multicenter Trial DAL-HD-90.

Dieckmann K, Pötter R, Hofmann J, Heinzl H, Wagner W, Schellong G; Pediatric Cooperative Hodgkin Disease Study Group of the GPOH.

Int J Radiat Oncol Biol Phys. 2003 Jul 1;56(3):644-52.

PMID:
12788169
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk